tiprankstipranks
TipRanksTop Financial ExpertsInsidersNew Enterprise Associates 17, L.P.

New Enterprise Associates 17, L.P. Insider Profile

4 Followers
New Enterprise Associates 17, L.P., Ten Percent Owner at Monte Rosa Therapeutics, holds 7.69M shares in Monte Rosa Therapeutics (Ticker: GLUE), holds ― shares in NeueHealth Inc (Ticker: NEUE), holds 1.09M shares in Korro Bio (Ticker: KRRO). Most recently, New Enterprise Associates 17, L.P. Bought ― shares of Monte Rosa Therapeutics on Jun 30, 2021 for an estimated value of 19.95M.
tipranks
New Enterprise Associates 17, L.P.

New Enterprise Associates 17, L.P.
Monte Rosa Therapeutics (GLUE)
Ten Percent Owner

Ranked #72,450 out of 98,624 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-28.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$103M
60.22%
39.78%
0.00%
A breakdown of New Enterprise Associates 17, L.P.'s holdings

Insider Roles

Korro Bio
(KRRO)
Ten Percent Owner
Monte Rosa Therapeutics
(GLUE)
Ten Percent Owner
NeueHealth Inc
(NEUE)
Ten Percent Owner
Roles that New Enterprise Associates 17, L.P. holds in companies

Most Profitable Insider Trade

Stock:
Korro Bio
(KRRO)
Rating:Informative Buy
Date:Apr 24, 2024 - Today
Return:0.00%
The most profitable trade made by New Enterprise Associates 17, L.P.

New Enterprise Associates 17, L.P.'s Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Monte Rosa Therapeutics
Jun 30, 2021
Ten Percent Owner
Informative Buy
19.95M
$40.92M
NeueHealth Inc
Ten Percent Owner
Korro Bio
Apr 24, 2024
Ten Percent Owner
Informative Buy
999.99K
$61.95M
List of latest transactions for each holding click on a transaction to see New Enterprise Associates 17, L.P.'s performance on stock

New Enterprise Associates 17, L.P. insider profile FAQ

What is the percentage of profitable transactions made by New Enterprise Associates 17, L.P.?
The percentage of profitable transactions made by New Enterprise Associates 17, L.P. is 0%.
    What is the average return per transaction made by New Enterprise Associates 17, L.P.?
    The average return per transaction made by New Enterprise Associates 17, L.P. is -28.70%.
      What stocks does New Enterprise Associates 17, L.P. hold?
      New Enterprise Associates 17, L.P. holds: GLUE, NEUE, KRRO stocks.
        What was New Enterprise Associates 17, L.P.’s latest transaction?
        New Enterprise Associates 17, L.P. latest transaction was an Informative Buy of $19.95M.
          What was New Enterprise Associates 17, L.P.'s most profitable transaction?
          New Enterprise Associates 17, L.P.’s most profitable transaction was an Informative Buy of KRRO stock on April 24, 2024. The return on the trade was 0.00%.
            What is New Enterprise Associates 17, L.P.'s role in Monte Rosa Therapeutics?
            New Enterprise Associates 17, L.P.'s role in Monte Rosa Therapeutics is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.